Clinical Research Institute

The FFB Clinical Research Institute (CRI) has objectives to accelerate the development of lead therapeutic candidates from Pre-IND stage into IND enabling phase and clinical trials (up through phase II) for treatments and cures of degenerative retinal diseases. FFB CRI also develops relationships with small business applicants through classical business development interactions and agreements.